基本面没变,港股混得不咋地的百奥赛图,能混好A股吗?尽管巨亏32.5亿以上,沈月雷2024年年薪42

中金在线
Sep 19

曾经在港股跌得鼻青脸肿的百奥赛图,如今又要来科创板“吸金”了。还是那个熟悉的味道,还是那些老问题,只不过换了个市场继续讲“千鼠万抗”的故事。9月24日,百奥赛图将迎来科创板上会审议的关键时刻。这家自称“创新技术驱动新药研发”的生物技术公司,早在2022年9月就已经在港交所上市,可惜股价表现惨不忍睹,从2023年6月的21.45港元/股一路跌至2024年底的5.60港元/股,跌幅超过74%。如今,在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10